Your browser doesn't support javascript.
loading
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis.
Gregory, Grace E; Islim, Abdurrahman I; Hannan, Cathal John; Jones, Adam P; Hammerbeck-Ward, Charlotte; Rutherford, Scott A; Freeman, Simon R; Lloyd, Simon; Kalamarides, Michel; Smith, Miriam J; Couper, Kevin; McBain, Catherine A; Jenkinson, Michael D; Brough, David; King, Andrew T; Evans, D Gareth; Pathmanaban, Omar N.
Afiliação
  • Gregory GE; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, UK.
  • Islim AI; Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Hannan CJ; The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
  • Jones AP; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, UK.
  • Hammerbeck-Ward C; Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Rutherford SA; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital NHS Foundation Trust, Salford, UK.
  • Freeman SR; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, UK.
  • Lloyd S; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital NHS Foundation Trust, Salford, UK.
  • Kalamarides M; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Smith MJ; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, UK.
  • Couper K; The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
  • McBain CA; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Jenkinson MD; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital NHS Foundation Trust, Salford, UK.
  • Brough D; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital NHS Foundation Trust, Salford, UK.
  • King AT; Department of Ears, Nose and Throat, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital NHS Foundation Trust, Salford, UK.
  • Evans DG; Department of Ears, Nose and Throat, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital NHS Foundation Trust, Salford, UK.
  • Pathmanaban ON; Department of Neurosurgery, Sorbonne Université Pitié-Salpêtrière, Paris, France.
Neurooncol Adv ; 5(Suppl 1): i94-i104, 2023 May.
Article em En | MEDLINE | ID: mdl-37287576
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article